SNN Stock Summary and Trading Ideas (Smith & Nephew Snats | NYSE:SNN)

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Smith & Nephew Snats trades on the NYSE stock market under the symbol SNN.

As of April 24, 2024, SNN stock price declined to $24.57 with 1,143,048 million shares trading.

SNN has a beta of 1.29, meaning it tends to be more sensitive to market movements. SNN has a correlation of 0.36 to the broad based SPY ETF.

SNN has a market cap of $10.74 billion. This is considered a Large Cap stock.

In the last 3 years, SNN stock traded as high as $44.47 and as low as $21.53.

The top ETF exchange traded funds that SNN belongs to (by Net Assets): AVDE, KOMP, DFIC, APIE, BINV.

SNN has underperformed the market in the last year with a return of -20.6%, while the SPY ETF gained +24.2%. In the last 3 month period, SNN fell short of the market, returning -11.2%, while SPY returned +4.6%. However, in the most recent 2 weeks SNN has outperformed the stock market by returning -0.4%, while SPY returned -2.7%.

SNN support price is $24.47 and resistance is $25.13 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SNN stock will trade within this expected range on the day.